BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33368252)

  • 1. Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB
    Bonilla-Del Río I; Puente N; Mimenza A; Ramos A; Serrano M; Lekunberri L; Gerrikagoitia I; Christie BR; Nahirney PC; Grandes P
    J Comp Neurol; 2021 Jun; 529(9):2332-2346. PubMed ID: 33368252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal cortical distribution of muscarinic M2 and cannabinoid-1 (CB1) receptors in adult male mice with or without chronic adolescent exposure to Δ9-tetrahydrocannabinol.
    Garzón M; Chan J; Mackie K; Pickel VM
    Cereb Cortex; 2022 Nov; 32(23):5420-5437. PubMed ID: 35151230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical characterization of the cannabinoid CB
    Gutiérrez-Rodríguez A; Puente N; Elezgarai I; Ruehle S; Lutz B; Reguero L; Gerrikagoitia I; Marsicano G; Grandes P
    J Comp Neurol; 2017 Feb; 525(2):302-318. PubMed ID: 27339436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
    Laaris N; Good CH; Lupica CR
    Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure.
    de Salas-Quiroga A; García-Rincón D; Gómez-Domínguez D; Valero M; Simón-Sánchez S; Paraíso-Luna J; Aguareles J; Pujadas M; Muguruza C; Callado LF; Lutz B; Guzmán M; de la Prida LM; Galve-Roperh I
    Neuropsychopharmacology; 2020 Apr; 45(5):877-886. PubMed ID: 31982904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent ethanol intake alters cannabinoid type-1 receptor localization in astrocytes of the adult mouse hippocampus.
    Bonilla-Del Rίo I; Puente N; Peñasco S; Rico I; Gutiérrez-Rodrίguez A; Elezgarai I; Ramos A; Reguero L; Gerrikagoitia I; Christie BR; Nahirney P; Grandes P
    Addict Biol; 2019 Mar; 24(2):182-192. PubMed ID: 29168269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
    Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
    Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice.
    Paronis CA; Nikas SP; Shukla VG; Makriyannis A
    Behav Pharmacol; 2012 Dec; 23(8):802-5. PubMed ID: 23075707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice.
    Eckard ML; Trexler KR; Kotson BT; Anderson KG; Kinsey SG
    Pharmacol Biochem Behav; 2020 Aug; 195():172966. PubMed ID: 32526216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ
    De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
    Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The loss of NMDAR-dependent LTD following cannabinoid self-administration is restored by positive allosteric modulation of CB1 receptors.
    Neuhofer D; Spencer SM; Chioma VC; Beloate LN; Schwartz D; Kalivas PW
    Addict Biol; 2020 Nov; 25(6):e12843. PubMed ID: 31733097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
    Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
    J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.
    Silva L; Harte-Hargrove L; Izenwasser S; Frank A; Wade D; Dow-Edwards D
    Neurosci Lett; 2015 Aug; 602():89-94. PubMed ID: 26118897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
    Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
    J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
    J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons.
    Nyíri G; Cserép C; Szabadits E; Mackie K; Freund TF
    Neuroscience; 2005; 136(3):811-22. PubMed ID: 16344153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.